COUNCIL OF MINISTERS OF HEALTH OF CENTRAL AMERICA

On September 3, the Executive Secretariat of the Council of Ministers of Health of Central America and the Dominican Republic (SE-COMISCA in Spanish) made available to drug manufacturers and distributors the Terms of Reference that they must comply with in order to participate in the second Exceptional Negotiation Event of Prices and Acquisition of Medicines and Personal Protection Supplies through the COMISCA Joint Negotiation. The list of drugs includes tocilizumab and remdesivir. The offer must be sent electronically to [email protected] with copy to [email protected] until September 24, 2021.

For this event, 4 drugs will be subject to negotiation, including Enoxaparin sodium and Remdesivir. In addition, Annex I also details the regional quantities to be negotiated for each drug and personal protective equipment. At the end of the negotiation event, the bidder that meets all the established requirements will be awarded supplier status. Once the contract or purchase order is signed, the awarded goods may be supplied immediately or within 45 calendar days.

The text mentions that, in order to participate in the joint negotiation, the information must be submitted digitally for each of the items offered, and 100% of the amount requested must be offered according to Annex I. The digital file must contain the information requested with the requirements of the technical offer and the administrative-legal requirements of the economic offer. The acquisitions are intended to support the Project “Public Health Support to the COVID Contingency Plan of the SICA Region”.